BIOPHYTIS
Updated 75 days ago
210 Broadway, Suite #201 Cambridge, MA 02139
Biophytis is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratoy failure in patients suffering from COVID-19. Our small molecules are aimed at stimulating biological resilience and are developed through a drug discovery platform based on a reverse pharmacology approach...
Our therapeutic approach is aimed at targeting and activating key biological resilience pathways that can protect against and counteract the effects of the multiple biological and environmental stresses, including inflammatory, oxidative and metabolic stresses that lead to age-related diseases.